204 related articles for article (PubMed ID: 16634013)
1. Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty.
Bonci A; Singh V
Ann Neurol; 2006 May; 59(5):733-4. PubMed ID: 16634013
[No Abstract] [Full Text] [Related]
2. Recent advances in Parkinson's disease.
Vécsei L
Ideggyogy Sz; 2002 Nov; 55(11-12):406-7. PubMed ID: 12632802
[No Abstract] [Full Text] [Related]
3. Suicide following duodenal levodopa infusion for Parkinson's disease.
Santos-García D; Macías M; Llaneza M; Aneiros A
Mov Disord; 2009 Oct; 24(13):2029-30. PubMed ID: 19645071
[No Abstract] [Full Text] [Related]
4. Addiction as aberrant learning-evidence from Parkinson's disease.
Dagher A
Addiction; 2012 Feb; 107(2):248-50. PubMed ID: 22248132
[No Abstract] [Full Text] [Related]
5. Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D; Giladi N
Parkinsonism Relat Disord; 2008; 14(4):273-80. PubMed ID: 17988927
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
Lim SY; Farrell MJ; Evans AH
Mov Disord; 2011 Jun; 26(7):1353-4. PubMed ID: 21449013
[No Abstract] [Full Text] [Related]
7. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
8. Levodopa therapy for Parkinson's disease: challenges and future prospects.
Olanow CW; Lees A; Obeso J
Mov Disord; 2008; 23 Suppl 3():S495-6. PubMed ID: 18781670
[No Abstract] [Full Text] [Related]
9. Medications for Parkinson's disease.
Whitney CM
Neurologist; 2007 Nov; 13(6):387-8. PubMed ID: 18090719
[No Abstract] [Full Text] [Related]
10. [Pathogenesis and basis of the therapy of Parkinson's disease].
van der Drift JH; Stoof JC
Ned Tijdschr Geneeskd; 1981 Apr; 125(16):620-5. PubMed ID: 6113554
[No Abstract] [Full Text] [Related]
11. Dopa-induced blood flow responses in nonhuman primates.
Hershey T; Black KJ; Carl JL; Perlmutter JS
Exp Neurol; 2000 Dec; 166(2):342-9. PubMed ID: 11085899
[TBL] [Abstract][Full Text] [Related]
12. A case of hedonistic homeostatic dysregulation.
Kessel BL
Age Ageing; 2006 Sep; 35(5):540-1. PubMed ID: 16799178
[TBL] [Abstract][Full Text] [Related]
13. Motor fluctuations in Parkinson's disease.
Crabb L
Prof Nurse; 2000 Jan; 15(4):273-7. PubMed ID: 10983145
[TBL] [Abstract][Full Text] [Related]
14. [Non-dopaminergic treatments for Parkinson's disease].
Derkinderen P
Rev Neurol (Paris); 2010 Oct; 166(10):811-5. PubMed ID: 20832090
[TBL] [Abstract][Full Text] [Related]
15. Treatment challenges in Parkinson's disease.
Welsh M
Nurse Pract; 2008 Jul; 33(7):32-8. PubMed ID: 18600170
[No Abstract] [Full Text] [Related]
16. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
Calabresi P; Mercuri NB; Di Filippo M
Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
[No Abstract] [Full Text] [Related]
17. Walking while talking: a dopamine-responsive task in early Parkinson's disease.
Kwon PS; Verghese J
J Am Geriatr Soc; 2005 Apr; 53(4):735-7. PubMed ID: 15817033
[No Abstract] [Full Text] [Related]
18. [Parkinson's diseases: power of search].
Agid Y
Rev Neurol (Paris); 2010 Oct; 166(10):755. PubMed ID: 20801469
[No Abstract] [Full Text] [Related]
19. [Initial management and adaptation of Parkinson's disease treatment].
Gérard JM
Rev Med Brux; 2008 Sep; 29(4):229-31. PubMed ID: 18949969
[TBL] [Abstract][Full Text] [Related]
20. Levodopa therapeutics for Parkinson's disease: new developments.
LeWitt PA
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S31-4. PubMed ID: 19131040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
